Pulmonary arterial hypertension treatments

Applications to fund PAH treatments may be considered by the Ministry of Health or Pharmac's PAH Panel.

Download the relevant form 

Always download a new form. Criteria may change. Applications on old forms will be rejected. 

ambrisentan(external link)

iloprost(external link)

epoprostenol(external link)

Send applications to fund sildenafil and bosentan to the Ministry of Health through the usual Special Authority application process.

Find the access criteria in the Schedule(external link)(external link)

Pulmonary Arterial Hypertension (PAH) Panel

The PAH Panel meets every 2 weeks.

Members of the panel

  • Dr Howard Wilson – General Practitioner/Pharmacologist
  • Dr Andrew Aitken – Cardiologist
  • Dr Lutz Beckert – Respiratory Physician
  • Dr Clare O'Donnell – Paediatric Congenital Cardiologist
  • Dr Kenneth Whyte – Respiratory Physician

Contact details for the panel 

Email PAH@pharmac.govt.nz

Fax 04 974 4858

Phone 0800 023 588 option 5

Post PAH Panel Coordinator
P O Box 10-254